Clinical Trial Update: A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study evaluated safety, tolerability, and pharmacokinetics of aripiprazole long-acting injectable depot in adults with schizophrenia; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Aripiprazole long-acting injectable depot (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2014-01-22